Mark Zaleski, Associated Press file
The rising price of EpiPen triggered concern as individuals and families find themselves squeezed between costs as high as $600 for a two-pack of the device, and health plans that demand more out of pocket from consumers. 
Getting your player ready...
An amendment added in the Senate’s Health and Human Services Committee would allow manufacturers to instead offer their own affordability program, provided it limited out-of-pocket costs to $60 and was available to anyone who isn’t covered by a government insurance program.
Already have an account Log In
This article is only available to subscribers
Trusted Local News
Standard Digital
$1 for 1 year
Offer valid for non-subscribers only
